{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:07:33Z","timestamp":1789398453843,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13071-015-0779-4","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T02:20:12Z","timestamp":1426645212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data"],"prefix":"10.1186","volume":"8","author":[{"given":"Hugo C","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon K","family":"Attah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas O","family":"Opoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwablah","family":"Awadzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette C","family":"Kuesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Gloria","family":"Bas\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"key":"779_CR1","unstructured":"World Health Organization. 18th Session of the Joint Action Forum. Bujumbura, Burundi; 2012. http:\/\/www.who.int\/apoc\/media\/Journal_du_FAC_day_4_Anglais.pdf"},{"key":"779_CR2","unstructured":"London Declaration on Neglected Tropical Diseases. Ending the neglect and reaching 2020 goals. London, UK; 2012. http:\/\/unitingtocombatntds.org\/downloads\/press\/ntd_event_london_declaration_on_ntds.pdf"},{"issue":"12","key":"779_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0169-4758(98)01342-8","volume":"14","author":"SEO Meredith","year":"1998","unstructured":"Meredith SEO, Dull HB. Onchocerciasis: The first decade of MectizanTM treatment. Parasitol Today. 1998;14(12):472\u20134.","journal-title":"Parasitol Today"},{"issue":"20","key":"779_CR4","first-page":"405","volume":"62","author":"M Eberhard","year":"2013","unstructured":"Eberhard M. Progress toward elimination of onchocerciasis in the Americas - 1993\u20132012. MMWR Morb Mortal Wkly Rep. 2013;62(20):405\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"779_CR5","first-page":"381","volume":"88","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec. 2013;88(36):381\u20135.","journal-title":"Wkly Epidemiol Rec"},{"key":"779_CR6","unstructured":"World Health Organization. Onchocerciasis - river blindness. http:\/\/www.who.int\/mediacentre\/factsheets\/fs095\/en\/"},{"issue":"7","key":"779_CR7","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1371\/journal.pntd.0000497","volume":"3","author":"L Diawara","year":"2009","unstructured":"Diawara L, Traor\u00e9 MO, Badji A, Bissan Y, Doumbia K, Goita SF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009;3(7):e497.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"779_CR8","doi-asserted-by":"crossref","first-page":"e1825","DOI":"10.1371\/journal.pntd.0001825","volume":"6","author":"MO Traor\u00e9","year":"2012","unstructured":"Traor\u00e9 MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6(9):e1825.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"779_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1179\/136485907X176355","volume":"101","author":"R Ndyomugyenyi","year":"2007","unstructured":"Ndyomugyenyi R, Lakwo T, Habomugisha P, Male B. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward. Ann Trop Med Parasitol. 2007;101(4):323\u201333.","journal-title":"Ann Trop Med Parasitol"},{"issue":"9578","key":"779_CR10","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(07)60942-8","volume":"369","author":"MY Osei-Atweneboana","year":"2007","unstructured":"Osei-Atweneboana MY, Eng JKL, Boakye DA, Gyapong JO, Prichard RK. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet. 2007;369(9578):2021\u20139.","journal-title":"Lancet"},{"key":"779_CR11","volume-title":"Onchocerciasis Control in Special Intervention Zones Including Sierra Leone in the OCP Area. Joint Programme Committee Report","author":"World Health Organization","year":"2002","unstructured":"World Health Organization, World Health Organization\/African Programme for Onchocerciasis Control. Onchocerciasis Control in Special Intervention Zones Including Sierra Leone in the OCP Area. Joint Programme Committee Report. Ouagadougou (Burkina Faso): World Health Organization\/African Programme for Onchocerciasis Control; 2002."},{"issue":"7","key":"779_CR12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciu467","volume":"59","author":"HC Turner","year":"2014","unstructured":"Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum N-K, Hopkins A, et al. Reaching the London declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis. 2014;59(7):923\u201332.","journal-title":"Clin Infect Dis"},{"key":"779_CR13","unstructured":"African Programme for Onchocerciasis Control. Conceptual and Operational Framework of Onchocerciasis Elimination with Ivermectin Treatment. WHO\/APOC; 2010. http:\/\/www.who.int\/apoc\/oncho_elimination_report_english.pdf"},{"issue":"12","key":"779_CR14","doi-asserted-by":"crossref","first-page":"e115886","DOI":"10.1371\/journal.pone.0115886","volume":"9","author":"LE Coffeng","year":"2014","unstructured":"Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, et al. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. Plos One. 2014;9(12):e115886.","journal-title":"Plos One"},{"issue":"9","key":"779_CR15","doi-asserted-by":"crossref","first-page":"e2452","DOI":"10.1371\/journal.pntd.0002452","volume":"7","author":"HC Turner","year":"2013","unstructured":"Turner HC, Osei-Atweneboana MY, Walker M, Tettevi EJ, Churcher TS, Asiedu O, et al. The cost of annual versus biannual community-directed treatment with ivermectin: Ghana as a case study. PLoS Negl Trop Dis. 2013;7(9):e2452.","journal-title":"PLoS Negl Trop Dis"},{"key":"779_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","volume":"2","author":"R Prichard","year":"2012","unstructured":"Prichard R, M\u00e9nez C, Lespine A. Moxidectin and the avermectins: Consanguinity but not identity. Int J Parasitol Drugs Drug Resist. 2012;2:134\u201353.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"6","key":"779_CR17","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1371\/journal.pntd.0002953","volume":"8","author":"K Awadzi","year":"2014","unstructured":"Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis. 2014;8(6):e2953.","journal-title":"PLoS Negl Trop Dis"},{"issue":"42","key":"779_CR18","doi-asserted-by":"crossref","first-page":"15265","DOI":"10.1073\/pnas.0502659102","volume":"102","author":"JAN Filipe","year":"2005","unstructured":"Filipe JAN, Boussinesq M, Renz A, Collins RC, Vivas-Martinez S, Grillet ME, et al. Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci U S A. 2005;102(42):15265\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"779_CR19","doi-asserted-by":"crossref","first-page":"e2169","DOI":"10.1371\/journal.pntd.0002169","volume":"7","author":"HC Turner","year":"2013","unstructured":"Turner HC, Churcher TS, Walker M, Osei-Atweneboana MY, Prichard RK, Bas\u00e1\u00f1ez MG. Uncertainty surrounding projections of the long-term impact of ivermectin treatment for human onchocerciasis. PLoS Negl Trop Dis. 2013;7(4):e2169.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"779_CR20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(08)70099-9","volume":"8","author":"MG Bas\u00e1\u00f1ez","year":"2008","unstructured":"Bas\u00e1\u00f1ez MG, Pion SDS, Boakes E, Filipe JAN, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(5):310\u201322.","journal-title":"Lancet Infect Dis"},{"key":"779_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1756-3305-7-241","volume":"7","author":"HC Turner","year":"2014","unstructured":"Turner HC, Walker M, Churcher TS, Bas\u00e1\u00f1ez MG. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections. Parasit Vectors. 2014;7:241.","journal-title":"Parasit Vectors"},{"key":"779_CR22","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","volume-title":"Infectious Diseases of Humans: Dynamics and Control","author":"RM Anderson","year":"1991","unstructured":"Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford Science Publications; 1991."},{"key":"779_CR23","unstructured":"World Health Organization. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization. WHO; 2003. http:\/\/www.who.int\/choice\/publications\/p_2003_generalised_cea.pdf"},{"issue":"9747","key":"779_CR24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","volume":"376","author":"MJ Taylor","year":"2010","unstructured":"Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet. 2010;376(9747):1175\u201385.","journal-title":"Lancet"},{"issue":"5","key":"779_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/eri.11.30","volume":"9","author":"CD Mackenzie","year":"2011","unstructured":"Mackenzie CD, Geary TG. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Expert Rev Anti Infect Ther. 2011;9(5):497\u2013501.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"779_CR26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/eri.13.49","volume":"11","author":"CD Mackenzie","year":"2013","unstructured":"Mackenzie CD, Geary TG. Addressing the current challenges to finding new anthelminthic drugs. Expert Rev Anti Infect Ther. 2013;11(6):539\u201341.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"779_CR27","doi-asserted-by":"crossref","unstructured":"Walker M, Specht S, Churcher TS, Hoerauf A, Taylor MJ, Bas\u00e1\u00f1ez MG: Therapeutic efficacy and macrofilaricidal activity of Doxycycline for the treatment of River Blindness. Clin Infect Dis 2014 Dec 23; pii: ciu1152 [Epub ahead of print].","DOI":"10.1093\/cid\/ciu1152"},{"issue":"1","key":"779_CR28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pt.2011.10.003","volume":"28","author":"CD Mackenzie","year":"2012","unstructured":"Mackenzie CD, Homeida MM, Hopkins AD, Lawrence JC. Elimination of onchocerciasis from Africa: possible? Trends Parasitol. 2012;28(1):16\u201322.","journal-title":"Trends Parasitol"},{"key":"779_CR29","doi-asserted-by":"crossref","unstructured":"Hotez PJ, Bottazzi ME, Zhan B, Makepeace BL, Klei TR, Abraham D, et al. The Onchocerciasis Vaccine for Africa\u2014TOVA\u2014Initiative. PLoS Negl Trop Dis. 2015;9(1):e0003422.","DOI":"10.1371\/journal.pntd.0003422"},{"key":"779_CR30","unstructured":"African Programme for Onchocerciasis Control. Report of the 36th session of the Technical Consultative Committee, Ouagadougou, Burkina Faso; 2013. http:\/\/www.who.int\/apoc\/about\/structure\/tcc\/TCC36_Final_Report_170513.pdf"},{"issue":"12","key":"779_CR31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.pt.2014.10.001","volume":"30","author":"HC Turner","year":"2014","unstructured":"Turner HC, Walker M, French MD, Blake IM, Churcher TS, Bas\u00e1\u00f1ez MG. Neglected tools for neglected diseases: mathematical models in economic evaluations. Trends Parasitol. 2014;30(12):562\u201370.","journal-title":"Trends Parasitol"},{"key":"779_CR32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0065-308X(08)00611-8","volume":"68","author":"MG Bas\u00e1\u00f1ez","year":"2009","unstructured":"Bas\u00e1\u00f1ez MG, Churcher TS, Grillet ME. Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol. 2009;68:263\u2013313.","journal-title":"Adv Parasitol"},{"issue":"4","key":"779_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pt.2012.02.004","volume":"28","author":"MG Bas\u00e1\u00f1ez","year":"2012","unstructured":"Bas\u00e1\u00f1ez MG, French MD, Walker M, Churcher TS. Paradigm lost: how parasite control may alter pattern and process in human helminthiases. Trends Parasitol. 2012;28(4):161\u201371.","journal-title":"Trends Parasitol"},{"issue":"9070","key":"779_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","volume":"350","author":"J Gardon","year":"1997","unstructured":"Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350(9070):18\u201322.","journal-title":"Lancet"},{"key":"779_CR35","unstructured":"World Health Organization. Criteria for certification of interruption of transmission\/elimination of human onchocerciasis. Report of a meeting held in Geneva, 28\u201329 September 2000. Geneva: WHO; 2001. WHO\/CDS\/CPE\/CEE\/2001.18a. http:\/\/www.oepa.net\/Documentos\/CriteriosCertificacionOMS\/WHO_CDS_CPE_CEE_2001.18a.pdf"},{"issue":"5","key":"779_CR36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijpara.2010.12.009","volume":"41","author":"HP Duerr","year":"2011","unstructured":"Duerr HP, Raddatz G, Eichner M. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol. 2011;41(5):581\u20139.","journal-title":"Int J Parasitol"},{"issue":"8","key":"779_CR37","doi-asserted-by":"crossref","first-page":"e2167","DOI":"10.1371\/journal.pntd.0002167","volume":"7","author":"D Engelman","year":"2013","unstructured":"Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7(8):e2167.","journal-title":"PLoS Negl Trop Dis"},{"key":"779_CR38","unstructured":"African Programme for Onchocerciasis Control. APOC statement on the 2015 annual letter of the Bill & Melinda Gates Foundation. http:\/\/www.who.int\/apoc\/APOC_Statement_on_annual_letter_of_BMGF.pdf?ua=1"},{"key":"779_CR39","unstructured":"African Programme for Onchocerciasis Control. Programme for the Elimination of Neglected Diseases in Africa (PENDA). WHO\/APOC; 2013. http:\/\/www.who.int\/apoc\/en_apoc_strategic_plan_2013_ok.pdf"},{"issue":"2","key":"779_CR40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4269\/ajtmh.2005.73.371","volume":"73","author":"KN Opara","year":"2005","unstructured":"Opara KN, Fagbemi OB, Ekwe A, Okenu DM. Status of forest onchocerciasis in the lower cross river basin, Nigeria: entomologic profile after five years of ivermectin intervention. Am J Trop Med Hyg. 2005;73(2):371\u20136.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-015-0779-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0779-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T22:18:19Z","timestamp":1717798699000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.parasitesandvectors.com\/content\/8\/1\/167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1186\/s13071-015-0779-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]},"article-number":"167"}}